The Influence of Intense Tai Chi Training on Physical Performance and Hemodynamic Outcomes in Transitionally Frail, Older Adults by Wolf, Steven L. et al.
Chemokines Are Associated With Delirium After
Cardiac Surgery
James L. Rudolph,1,10 Basel Ramlawi,2,6 George A. Kuchel,4 Janet E. McElhaney,3,4,5 Dongxu Xie,3,4
Frank W. Sellke,6 Kamal Khabbaz,6 Sue E. Levkoff,9 and Edward R. Marcantonio7,8
1Geriatric Research, Education, and Clinical Center, VA Boston Healthcare System, Massachusetts.
2Division of Cardiac Surgery, University of Western Ontario, London, Ontario, Canada.
3Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington.
4University of Connecticut Center on Aging, University of Connecticut Health Center, Farmington.
5Geriatric Medicine, University of British Columbia, Vancouver, Canada.
Divisions of 6Cardiac Surgery, 7General Medicine and Primary Care, and 8Gerontology,
Beth Israel Deaconess Medical Center, Boston, Massachusetts.
9Department of Psychiatry and 10Division of Aging, Brigham and Women’s Hospital, Boston, Massachusetts.
Background. Delirium has been hypothesized to be a central nervous system response to systemic inflammation during
a state of blood–brain barrier compromise. The purpose of this study was to compare postoperative changes in groups of
inflammatory markers in persons who developed delirium following cardiac surgery and matched controls without
delirium.
Methods. Serum samples were drawn from 42 patients undergoing cardiac surgery preoperatively and postoperatively
at 6 hours and postoperative day 4. The serum concentrations of 28 inflammatory markers were determined with
a microsphere flow cytometer. A priori, inflammatory markers were assigned to five classes of cytokines. A class z score
was calculated by averaging the standardized, normalized levels of the markers in each class. Beginning on postoperative
day 2, patients underwent a daily delirium assessment.
Results. Twelve patients with delirium were matched by surgical duration, age, and baseline cognition to 12 patients
without delirium. At the 6-hour time point, patients who went on to develop delirium had higher increases of chemokines
compared to matched controls (class z score 0.3 6 1.0, p , .05). Among the five classes of cytokines, there were no other
significant differences between patients with or without delirium at either the 6 hour or postoperative day 4 assessments.
Conclusion. After cardiac surgery, chemokine levels were elevated in patients who developed delirium in the early
postoperative period. Because chemokines are capable of disrupting blood–brain barrier integrity in vitro, future studies
are needed to define the relationship of these inflammatory mediators to delirium pathogenesis.
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DELIRIUM, a multifactorial geriatrics syndrome (1), isa common complication of cardiac surgery, occurring
in 32%–72% of older patients (2). Postoperative delirium
has been associated with increased mortality (3), post-
operative complications (3), functional decline (4), and
increased cost (5). Despite the high prevalence and negative
sequelae of postoperative delirium, its pathophysiology
remains unknown (6,7). Nevertheless, it has been proposed
that systemic inflammation may actually contribute to
delirium pathogenesis by compromising blood–brain barrier
(BBB) integrity (8–10).
The magnitude of the operative inflammatory response
has been implicated as a risk factor of neurocognitive de-
cline, including delirium, after surgery (11–13). Normally,
the BBB inhibits cytokines and many medications from
passing across capillaries into the brain parenchyma (14).
Thus, the brain is relatively protected from the effects of
systemic inflammation. Delirium is felt to be a central
nervous system (CNS) manifestation of a systemic disease
state that may indeed cross the BBB. In many of the situa-
tions in which delirium is likely to occur (e.g., infections,
postoperative states), BBB integrity may be compromised.
Chemokines are locally acting cytokines that enhance
migration of inflammatory cells into the brain by compro-
mising the BBB (15,16). When BBB integrity is compro-
mised, the brain becomes more susceptible to the effects of
systemic inflammation (10,15).
The inflammatory response to surgery involves a complex
coordination of cytokines, chemokines, and adaptive phys-
iological responses required to maintain homeostasis. A
transient postoperative increase in levels of circulating in-
flammatory markers (10–100 times more than baseline) has
been hypothesized to result from tissue damage, adrenal
stress response, cardiopulmonary bypass, and/or anesthesia
(17–19). Inflammatory marker levels peak 6–24 hours
postoperatively and return to baseline levels over 2–4 days
(18,19). Inflammatory cytokines are produced by activated
immune cells and are involved in the early amplification of
the inflammatory response. Chemokines rapidly mediate
leukocyte movement to sites of inflammation, including
across the BBB. Cytokines that promote a T-helper 1 (TH-1)
leukocyte and cytotoxic T-lymphocyte (CTL) response
increase cell proliferation and CD8 expression. Cytokines
that promote a T-helper 2 (TH-2) response are responsible
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for B-cell proliferation and humoral immune maturation. As
a result of their respective roles, inflammatory cytokines and
chemokines should be elevated early, with cytokines
promoting TH-1/CTL and TH-2 responses increased during
later stages of the postoperative inflammatory response.
The purpose of this study was to determine if a difference
exists in the postoperative pattern of change in a priori
determined classes of inflammatory markers in matched
patients with and without delirium after cardiac surgery. We
hypothesized that, as compared to their baseline levels,
patients with delirium would have (i) increased inflamma-
tory cytokines and chemokines 6 hours postoperatively and
(ii) increased cytokines that promote TH-1/CTL and TH-2
responses 4 days postoperatively.
METHODS
Patient Enrollment
We prospectively enrolled 42 patients undergoing elec-
tive or urgent cardiac surgery at an academic medical center.
Eligible procedures included coronary artery bypass graft
(CABG), valve replacement, and combined CABG–valve
surgery. Patients with preoperative delirium, active sub-
stance abuse, psychiatric disease, and/or aortic procedures
were excluded. Patients provided their written informed
consent, and the study was approved by the institutional
review board.
Anesthetic and Surgical Methods
Operative procedures were completed by three surgeons
using the same conventional approach, including induction
of general anesthesia, invasive monitoring, midline sternot-
omy, and systemic heparinization. Mild hypothermic car-
diopulmonary bypass (CPB) with cold-blood hyperkalemic
cardioplegia was used. All patients received antibiotics
preoperatively and up to 48 hours postoperatively.
Measurement of Inflammation
Prior to surgery and 6 hours after surgery in the intensive
care unit (ICU), blood samples were collected from the cen-
tral venous line. Postoperative day 4 samples were collected
peripherally. Blood samples were processed, and serum
samples were frozen at 808C until the time of assay.
Samples were analyzed on a Luminex 100 dual-laser,
microsphere flow cytometer (Luminex, Austin, TX) using
combined BioSource human cytokine 25-plex and death
receptor 3-plex bead kits (Invitrogen, Carlsbad, CA). Samples
were incubated with the beads for 2 hours, washed, incubated
with biotinylated detector antibodies for 1 hour, washed,
incubated for 30 minutes with a conjugated fluorescent
protein, and again washed. For each inflammatory marker
measured, a standard curve was developed using four known
concentration standards. The fluorescence of each inflamma-
tory marker was converted to a concentration using the
standard curve. In accordance with standard practice, samples
with undetectable cytokine levels were entered at half of the
minimum detection level derived from the standard curve.
A priori and based on the consensus of three experts in
the study of inflammation, inflammatory markers were as-
signed to one of five classes: (i) inflammatory cytokines; (ii)
cytokines that promote TH-1/CTL responses; (iii) cytokines
that promote TH-2 responses; (iv) chemokines, and (v)
lymphatic chemokines. Interleukin 17 (IL-17) and death
receptor 5 were not assigned to any class and were analyzed
independently.
Delirium
A brief delirium assessment (,15 minute) was performed
preoperatively and daily postoperatively, beginning on day
2. Patients were not assessed on postoperative days 0 or 1
because of the intensive medical care required after CABG
surgery. Delirium was assessed using the diagnostic algo-
rithm of the Confusion Assessment Method (CAM) (20).
Prior to its completion, a standardized mental status inter-
view was conducted, including the Mini-Mental State
Examination (MMSE) (21), digit span, the Delirium Symp-
tom Interview (DSI) (22), and the Memorial Delirium
Assessment Scale (MDAS) (23). The MMSE is a screening
assessment of mental status. The digit span asks patients to
repeat a series of random digits forward and backward and is
an assessment of working memory and attention. The DSI is
an interview for eliciting eight key symptoms of delirium.
The MDAS is a severity scale for delirium. This combined
assessment for delirium has been shown to be highly reliable
(j¼ 0.95) (24) when administered by trained, nonclinician
interviewers.
Matching
An analyst unaware of study aims and inflammatory
marker results matched patients with delirium to patients
who did not develop delirium on the basis of surgery
duration (690 minutes), age (65 years) and baseline
MMSE (63 points), respectively. Because of the small
and diverse sample, the matching process was appropriate to
allow comparisons of baseline characteristics that might
influence the inflammatory response. We used a Student
t test to compare the baseline characteristics of the matched
controls to those of the patients with delirium and to those of
the unmatched group.
Statistics
As the distribution of circulating inflammatory markers is
generally nonnormal, we log normalized the inflammatory
marker concentrations. To calculate the postoperative inflam-
matory response, we subtracted the baseline log-normalized
concentration from the postoperative log-normalized con-
centration (log[Postoperative] log[Baseline]). The concen-
trations among the inflammatory markers were standardized
to the mean and standard deviation of the matched non-
delirious control group (marker z score). We created a class z
score by averaging the marker z scores of the inflammatory
markers within each class. We compared the mean z score
among the assigned classes using a Student t test. All
statistical calculations were performed using SPSS version
11.5.0 (SPSS Inc., Chicago, IL).
RESULTS
Among the 42 patients enrolled, 12 (29%) developed
delirium. Table 1 describes the baseline characteristics of
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the matched control and delirium individuals, as well as the
unmatched patients. There were no significant differences
between matched controls and patients with delirium in the
parameters used for matching (age, MMSE score, and
surgery time). Interestingly, no patients younger 60 years
developed delirium. Matched controls were more likely to
have a diagnosis of hypertension than were the patients with
delirium, but all patients were taking preoperative medi-
cations that lower blood pressure. The unmatched patients
were significantly younger (59.9 6 5.5 years) and had
significantly higher preoperative MMSE scores (28.6 6 1.5)
than the matched controls. There was no significant
difference in preoperative comorbidity, medication usage,
or surgical time among the groups.
Preoperative levels of inflammatory markers are compared
in Table 2. Class z scores in patients with delirium did not
differ significantly from those of matched controls. Thus, the
patients were well matched for baseline inflammatory levels.
Also, based on these data, it does not appear that greater
levels of baseline inflammation are a risk factor for delirium.
Table 3 depicts the postoperative change in circulating
inflammatory markers. At 6 hours postoperatively, circulat-
ing levels of chemokines were significantly higher (Marker z
score .0) in patients who went on to develop delirium than
in matched controls without delirium (p , .05). However,
the inflammatory cytokine group was not elevated. On the
4th postoperative day, the levels of cytokines that promote
TH-1/CTL and TH-2 responses tended to be lower (Class z
scores ,0) in patients who developed delirium, yet this
difference was not statistically significant.
DISCUSSION
Delirium after surgery has been hypothesized to occur as
a result of the inflammatory response (9). However, the basic
pathophysiology is not understood. This study used new
technology to examine peripheral inflammatory marker re-
sponses to cardiac surgery in patients with delirium and in
matched controls without delirium. Based on the temporal
nature of typical inflammatory responses, we hypothesized
that inflammatory cytokines and chemokines would be
initially elevated because of their role in the control of sub-
sequent inflammatory responses and that cytokines known to
promote TH-1/CTL and TH-2 responses would be elevated on
postoperative day 4. We postulated that at both times delirium
would be associated with a greater increase in circulating
inflammatory marker response compared to that of patients
without delirium. Unexpectedly, our findings indicate a much
more restricted inflammatory response. In the immediate post-
operative periods, patients who later developed delirium had
increased chemokine levels, but levels of classical inflamma-
tory cytokines were similar between those who developed
delirium and matched controls. At 4 days after surgery, pa-
tients with delirium tended to demonstrate smaller increases
of cytokines that promote the TH-1/CTL and TH-2 response.
Chemokines have not been traditionally included in
delirium research, but recent studies have added biological
plausibility to a hypothesis implicating these inflammatory
mediators in the earliest events contributing to delirium.
Although our study was not designed to detect changes in
levels of individual chemokines, elevations in inflammatory
cytokines (particularly IL-6) have been linked to post-
operative delirium in other studies (25,26). Chemokines are
known to promote leukocyte migration into the CNS (27)
and, in the case of chemokine C-C motif ligand 2 (CCL2),
mediate BBB disruption in the context of ischemic injury
(15). Moreover, at least three important risk factors for
delirium—aging (28,29), brain injury(29), and anticholin-
ergic medications (30)—have been associated with greater
basal and induced CCL-2 activity. Our observed elevations
in systemic chemokine levels are quite transient, with no
detectable differences between individuals with and without
delirium by the 4th postoperative day.
The cause of the nonsignificant trend toward lower TH-1/
CTL and TH-2 responses in individuals with delirium at
postoperative day 4 is unclear. We propose three hypotheses
for this finding. First, there may be a lack of reserve capacity
to mount an inflammatory response. Second, most of these
cytokine elevations are very modest (exceptions: IL-4,
IL-10), and these substances exerted predominantly local
autocrine effects and were being consumed locally (9).
Third, stress mediators, such as glucocorticoids, are likely to
be elevated in the setting of delirium (31) and tend to
suppress TH-1 immunity, while promoting TH-2 immunity
(32). Thus, as we learn more about the nature of the
Table 1. Baseline Characteristics of the Matching Procedure
Patient Characteristic
No Delirium
(N ¼ 12)
Delirium
(N ¼ 12)
Unmatched
(N ¼ 18)
Age, y 73.9 (8.4) 74.7 (7.0) 59.9 (5.5)*
Male gender, n (%) 9 (75%) 11 (92%) 17 (94%)
Charlson Comorbidity Index 2.1 (2.0) 2.9 (1.9) 1.7 (1.6)
Number of medications 7.9 (2.4) 7.2 (2.7) 6.2 (2.9)*
Body mass index, kg/m2 30.1 (6.1) 26.7 (4.1) 31.3 (5.7)
MMSE 25.3 (3.6) 26.1 (2.9) 28.6 (1.5)*
GDS 2.5 (2.2) 2.5 (1.3) 2.4 (2.1)
History of n (%):
Hypertension 10 (83%) 5 (42%)* 10 (62%)
Diabetes 5 (42%) 4 (33%) 7 (44%)
Hyperlipidemia 8 (67%) 5 (42%) 7 (44%)
WBC (per mL) 8.3 (2.8) 7.4 (2.3) 7.4 (1.6)
Hematocrit, % 35.9 (5.3) 35.1 (4.4) 36.0 (5.4)
Creatinine, mg/dL 1.9 (2.6) 1.2 (0.4) 1.1 (0.5)
Medications, n (%)
Aspirin 12 (100%) 10 (83%) 16 (89%)
NSAIDs 0 (0%) 2 (17%) 2 (11%)
Steroids 0 (0%) 1 (8%) 1 (6%)
Beta-blockers 10 (83%) 7 (58%) 14 (78%)
ACE-I/ARB 7 (58%) 6 (50%) 12 (67%)
CCB 3 (25%) 4 (33%) 4 (22%)
Nitrate 3 (25%) 2 (17%) 2 (11%)
Diuretic 4 (33%) 7 (58%) 6 (33%)
Surgery time, min 210.3 (53.9) 202.8 (57.3) 221.1 (54.9)
CPB time, min 90.4 (38.6) 91.4 (50.4) 94.6 (36.3)
Notes: Values are shown as mean 6 standard deviation. There were no
differences between patients with delirium (n ¼ 12) and the matched controls
without delirium (n ¼ 12). The unmatched group (n ¼ 18) was significantly
younger and had increased Mini-Mental State Examination (MMSE) scores.
*p , .05 compared to No Delirium group.
ACE-I/ARB ¼ angiotensin-converting enzyme inhibitor/angiotensin re-
ceptor blocker; CCB ¼ calcium channel blocker; CPB ¼ cardiopulmonary
bypass; GDS ¼ Geriatric Depression Scale (15 point scale); NSAIDs ¼
nonsteroidal antiinflammatory drugs; WBC ¼ white blood cell count.
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relationships among different cytokines, we can better un-
derstand the cognitive effects of cytokines.
The inflammatory response is a highly complex and dy-
namic inter-related process during which any one cytokine
can modulate a proinflammatory and/or antiinflammatory
response depending on multiple clinical, physiologic, and
immune considerations. Traditionally, studies of inflamma-
tion and geriatric syndromes measured individual inflam-
matory markers using enzyme linked immunosorbent assays
(ELISAs) to measure a single protein in a blood sample
(33,34). Although reliable, ELISAs are time-, labor-, and
sample-consuming, resulting in increased cost and in-
efficient use of available blood samples. The dual-channel
microsphere flow cytometer is a recent advance that allows
assessment of multiple cytokines simultaneously by using
a blood sample (100 microliters) comparable to that required
for an individual ELISA. As with all new technologies,
some cautionary notes have been raised. First, a reliable
uniplex assay cannot be merely added into a reliable mul-
tiplex array without additional validation (35). Studies have
demonstrated good correlations, but often poor concurrence
of quantitative values between multiplex kits made by
different manufacturers (36), as well as between multiplex
kits and ELISA measurements (35). Because inflammatory
markers are likely to be interdependent, grouping markers
into classes for analysis increases statistical power and
reduces the likelihood of finding a spurious association as a
result of multiple testing. Nevertheless, carefully performed
multiplex assays offer investigators opportunities for eval-
uating varied elements of inflammatory responses in the
same individual over time.
Our study’s approach to examine peripheral cytokine
panels after cardiac surgery has both strengths and limita-
tions. Its major advantage is the utilization of the micro-
sphere flow cytometer, which allowed the measurement of
28 cytokines simultaneously. Thus, we were able to acquire
a broad picture of changes in many cytokines and group
them according to their roles within the overall inflammation
response. However, the number of inflammatory markers
measured increases the number of individuals needed to
definitively draw conclusions about the relationship between
delirium and inflammation. In this study, we focused on class
effects because the large number of inflammatory markers
limited the power to make definitive statements regarding
Table 2. Preoperative Inflammatory Markers
Raw (pg/lL) Normalized Marker z Scores Class z Scores
Class Cytokine No Delirium Delirium No Delirium Delirium No Delirium Delirium No Delirium Delirium p Value
Group 1: Inflammatory IL-1b 678 (1019.5) 368.9 (1027.5) 4.6 (2.4) 3.4 (2.0) 0.0 (1.0) 0.5 (0.9) 0.0 (1.0) 0.1 (1.1) .45
IL-1Ra 327 (518) 247.8 (495.3) 4.3 (2.0) 4.1 (1.8) 0.0 (1.0) 0.1 (0.9)
IL-6 295.8 (422.7) 144.1 (179.3) 5.0 (1.2) 4.2 (1.4) 0.0 (1.0) 0.7 (1.2)
IFN-a 19.6 (29.1) 45.9 (74.2) 2.4 (1.0) 2.7 (1.4) 0.0 (1.0) 0.4 (1.5)
TNF-a 18.3 (21.3) 30 (35.5) 2.4 (0.9) 2.7 (1.2) 0.0 (1.0) 0.3 (1.3)
TNF-R1 1024.6 (906) 831.3 (895.4) 6.5 (1.0) 6.3 (1.0) 0.0 (1.0) 0.2 (1.0)
TNF-R2 7470.2 (3056.6) 7441.9 (2125.8) 8.8 (0.4) 8.9 (0.3) 0.0 (1.0) 0.1 (0.7)
Group 2: T-Helper 1 IL-2 532.3 (838.8) 272.4 (715.9) 4.0 (2.6) 3.1 (2.1) 0.0 (1.0) 0.3 (0.8) 0.0 (1.0) 0.1 (1.8) .79
IL-2R 87.5 (91.1) 81 (68.2) 4.1 (0.9) 4.0 (0.9) 0.0 (1.0) 0.0 (1.0)
IL-7 65.1 (112.9) 52.2 (83.6) 3.0 (1.5) 2.9 (1.4) 0.0 (1.0) 0.1 (1.0)
IL-12p40_p70 72 (58.5) 94.4 (91.9) 4.0 (0.8) 4.1 (1.0) 0.0 (1.0) 0.1 (1.3)
IL-15 164.8 (256.9) 179 (255.2) 4.2 (1.4) 4.1 (1.6) 0.0 (1.0) 0.1 (1.1)
IFN-c 26.5 (45.6) 78.4 (141.2) 2.6 (1.0) 3.1 (1.6) 0.0 (1.0) 0.5 (1.6)
IP-10 1011.4 (598.9) 1315.3 (1152.7) 6.8 (0.5) 6.5 (2.0) 0.0 (1.0) 0.6 (3.8)
Group 3: T-Helper 2 IL-4 25.9 (39.4) 54.9 (102.4) 2.6 (1.0) 2.8 (1.4) 0.0 (1.0) 0.2 (1.4) 0.0 (1.0) 0.1 (1.3) .59
IL-5 60.7 (76) 73.1 (127.8) 3.3 (1.4) 3.1 (1.5) 0.0 (1.0) 0.1 (1.1)
IL-10 109 (107.2) 130.8 (147) 4.3 (1.0) 4.4 (1.0) 0.0 (1.0) 0.1 (1.0)
IL-13 25.7 (21.3) 49.9 (84.6) 3.0 (0.6) 3.2 (1.0) 0.0 (1.0) 0.3 (1.8)
Group 4: Chemokines MIP-1a 121.5 (197.1) 113.4 (196.5) 3.6 (1.6) 3.4 (1.7) 0.0 (1.0) 0.1 (1.0) 0.0 (1.0) 0.2 (1.2) .28
MIP-1b 53.3 (68.8) 94.8 (115) 3.4 (1.1) 3.6 (1.5) 0.0 (1.0) 0.2 (1.4)
MIG 42 (48.1) 81.9 (114.8) 3.1 (1.2) 3.3 (1.8) 0.0 (1.0) 0.2 (1.4)
Eotaxin 593.4 (548) 421.2 (222.1) 6.1 (0.7) 5.9 (0.7) 0.0 (1.0) 0.4 (1.0)
RANTES 7241.2 (1521.1) 6445.7 (1427.6) 8.9 (0.2) 8.7 (0.2) 0.0 (1.0) 0.6 (1.2)
CCL-2 558 (419.7) 424.7 (257.2) 6.1 (0.6) 5.8 (0.8) 0.0 (1.0) 0.5 (1.2)
Group 5: Lymphatic
Chemokines
IL-8 674.9 (1667.5) 146.7 (133.6) 4.7 (1.9) 4.2 (1.6) 0.0 (1.0) 0.3 (0.9) 0.0 (1.0) 0.2 (0.8) .52
GM–CSF 60.4 (116.5) 35.8 (50.6) 2.9 (1.4) 2.8 (1.2) 0.0 (1.0) 0.1 (0.8)
Miscellaneous IL-17 22.7 (29.7) 38.5 (51.3) 2.7 (0.9) 3 (1.1) 0.0 (1.0) 0.4 (1.3)
DR5 87.7 (76.3) 88.7 (62.4) 3.9 (1.2) 4.1 (1.0) 0.0 (1.0) 0.2 (0.8)
Notes: This table describes the process leading to inflammatory marker comparisons. Raw scores were log normalized because of data skew. Normalized scores
were standardized to a mean of 0 and standard deviation (SD) of 1 (z scores) in the population without delirium (marker z scores). Thus, the marker z zcores for the ‘‘No
Delirium’’ group are 0 with an SD of 1. This step allows the comparison of the individual inflammatory markers and the effect of inflammatory class (class z score). The
class z score is the average of the marker z scores in the designated class. At baseline, there were no significant class z score differences between patients with delirium
and matched controls.
IL ¼ interleukin; IFN ¼ interferon; TNF ¼ tumor necrosis factor; TNF-R ¼ tumor necrosis factor receptor; MIP ¼ macrophage inflammatory protein; MIG ¼
monokine induced by IFN-c; RANTES ¼ regulated upon activation, normal T-cell expressed, and secreted; CCL ¼ C-C motif ligand; GM–CSF ¼ granulocyte
macrophage colony-stimulating factor; DR5 ¼ death receptor 5; IP ¼ interferon inducible protein.
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any individual cytokine. Although our study would clearly
benefit from more patients with and without delirium, this
type of analysis is commonly used in the gene microarray
literature, where the expression of thousands of different
genes may be measured in a single individual to identify
specific areas of interest for future research.
Our study is limited by the number of patients. The
matched analysis provided a baseline level of risk adjust-
ment. Inflammation and delirium can be affected by
cognitive performance, age, and the surgical procedure.
By matching for these factors, we were able to control some
of the baseline risk. In future studies with more patients, it
would be helpful to match by gender, comorbidity, and
atherosclerosis burden, which can affect inflammation (9).
Because delirium is a disorder of the CNS, our assump-
tion that serum levels of inflammatory markers parallel those
in the CNS inflammatory response cannot be definitively
proven at this time. However, we did find associations with
the inflammatory response and delirium, suggesting that
they may indeed be related. Moreover, because delirium
may be associated with breakdown of the BBB, serum levels
may indeed be correlated with CNS levels, although this
hypothesis requires further evaluation.
Conclusion
By using new technology to examine a large panel of
cytokines, we found that early postoperative increased eleva-
tions of chemokines were associated with the development
Table 3. Postoperative Change in Inflammatory Markers at 6 Hours (Intensive Care Unit [ICU]) and 4 Days (Postoperative Day [POD] 4)
ICU POD 4
Marker z Scores Class z Scores Marker z Scores Class z Scores
Class No Delirium Delirium No Delirium Delirium p Value No Delirium Delirium No Delirium Delirium p Value
Group 1: Inflammatory
IL-1b 0.0 (1.0) 0.5 (0.8) 0.0 (1.0) 0.1 (1.0) .57 0.0 (1.0) 0.1 (0.7) 0.0 (1.0) 0.0 (0.9) .75
IL-1Ra 0.0 (1.0) 0.1 (0.9) 0.0 (1.0) 0.2 (0.8)
IL-6 0.0 (1.0) 0.5 (0.9) 0.0 (1.0) 0.2 (1.0)
IFN-a 0.0 (1.0) 0.4 (1.4) 0.0 (1.0) 0.5 (1.0)
TNF-a 0.0 (1.0) 0.5 (1.0) 0.0 (1.0) 0.5 (0.8)
TNF-R1 0.0 (1.0) 0.3 (0.9) 0.0 (1.0) 0.2 (1.1)
TNF-R2 0.0 (1.0) 0.1 (0.7) 0.0 (1.0) 0.4 (0.8)
Group 2: T-Helper 1
IL-2 0.0 (1.0) 0.2 (0.6) 0.0 (1.0) 0.2 (1.2) .34 0.0 (1.0) 0.0 (0.8) 0.0 (1.0) 0.3 (1.2) .10
IL-2R 0.0 (1.0) 0.7 (0.8) 0.0 (1.0) 0.2 (0.8)
IL-7 0.0 (1.0) 0.2 (0.8) 0.0 (1.0) 0.1 (0.8)
IL-12p40_p70 0.0 (1.0) 0.3 (0.9) 0.0 (1.0) 0.6 (0.9)
IL-15 0.0 (1.0) 0.0 (1.0) 0.0 (1.0) 0.3 (0.7)
IFN-c 0.0 (1.0) 0.4 (1.6) 0.0 (1.0) 0.4 (1.1)
IP-10 0.0 (1.0) 0.8 (2.0) 0.0 (1.0) 0.3 (2.4)
Group 3: T-Helper 2
IL-4 0.0 (1.0) 0.4 (1.6) 0.0 (1.0) 0.1 (1.1) .80 0.0 (1.0) 0.4 (1.1) 0.0 (1.0) 0.3 (0.9) .08
IL-5 0.0 (1.0) 0.1 (0.9) 0.0 (1.0) 0.1 (0.8)
IL-10 0.0 (1.0) 0.4 (0.8) 0.0 (1.0) 0.3 (0.8)
IL-13 0.0 (1.0) 0.3 (0.7) 0.0 (1.0) 0.5 (0.9)
Group 4: Chemokines
MIP-1a 0.0 (1.0) 0.1 (1.0) 0.0 (1.0) 0.3 (1.0)* .04 0.0 (1.0) 0.3 (0.9) 0.0 (1.0) 0.0 (1.1) .68
MIP-1b 0.0 (1.0) 0.1 (0.9) 0.0 (1.0) 0.5 (1.0)
MIG 0.0 (1.0) 0.5 (1.5) 0.0 (1.0) 0.4 (1.1)
Eotaxin 0.0 (1.0) 0.7 (0.6)* 0.0 (1.0) 0.8 (0.8)*
RANTES 0.0 (1.0) 0.3 (0.6) 0.0 (1.0) 0.0 (1.2)
CCL-2 0.0 (1.0) 0.8 (0.8)* 0.0 (1.0) 0.5 (0.9)
Group 5: Lymphatic Chemokines
IL-8 0.0 (1.0) 0.4 (0.8) 0.0 (1.0) 0.2 (0.8) .44 0.0 (1.0) 0.1 (1.3) 0.0 (1.0) 0.1 (1.1) .93
GM–CSF 0.0 (1.0) 0.0 (0.8) 0.0 (1.0) 0.1 (0.9)
Miscellaneous
IL-17 0.0 (1.0) 0.6 (1.1) 0.0 (1.0) 0.5 (0.8)
DR5 0.0 (1.0) 0.2 (0.7) 0.0 (1.0) 0.4 (0.8)
Notes: The postoperative inflammatory marker concentration (ICU and POD 4) was divided by the preoperative concentration (fold change) and log normalized. To
obtain the change z score, the population was standardized with a mean of 0 and standard deviation of 1 relative to the control group without delirium. We present the
change z score for each inflammatory marker and class change z score, which represents the mean of the inflammatory marker class. Overall, circulating cytokine
increased after surgery at both times. Among patients with delirium, there was a greater increase in chemokine class levels in the ICU and a trend toward decreased T-
helper 1 and T-helper 2 class responses at POD 4.
*p , .05.
IL ¼ interleukin; IFN ¼ interferon; TNF ¼ tumor necrosis factor; TNF-R ¼ tumor necrosis factor receptor; MIP ¼ macrophage inflammatory protein; MIG ¼
monokine induced by IFN-c; RANTES ¼ regulated upon activation, normal T-cell expressed, and secreted; CCL ¼ C-C motif ligand; GM–CSF ¼ granulocyte
macrophage colony stimulating factor; DR5 ¼ death receptor 5; IP ¼ interferon inducible protein.
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of delirium after cardiac surgery. Although more research is
needed to definitively establish a causative link, our
evidence suggests that delirium may be at least in part
mediated via chemokines, as these potent immune mediators
attract inflammatory cells to the site of brain injury, may
cause breakdown of the BBB, and may ultimately suppress
T-cell–mediated immunity in patients who develop delirium
in the postoperative period. These results represent a poten-
tial pathophysiologic mechanism of delirium after surgery.
Moreover, after being replicated in a larger sample that will
allow analysis of individual chemokines or cytokines, our
findings may also offer a first potential target for mechanism-
driven interventions for this common and morbid syndrome.
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